SCHEMBL8730046

SCHEMBL8730046

COc1cc2c(cc1OC)C(CCN1CCN(c3ccccc3OC)CC1)(SC)C(=O)N2

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 4/20 0.55
DRD2 P14416 8/20 0.52
DRD3 P35462 6/20 0.52
DRD4 P21917 4/20 0.52
MEN1 O00255 2/20 0.48
HTR1A P08908 2/20 0.48
KMT2A Q03164 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
ADRA1D P25100 2/20 0.47
ADRA1A P35348 2/20 0.47
ADRA1B P35368 2/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
ALOX12 P18054 1/20 0.47
HIF1A Q16665 1/20 0.47
HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8705641 0.75 HTR7 (0.67) HTR7DRD2DRD3MEN1HTR1A
SCHEMBL10641480 0.71 DRD2 (0.61) HTR7DRD2DRD3DRD4MEN1
SCHEMBL2984584 0.71 HTR7 (1.00) HTR7
SCHEMBL10641064 0.70 DRD2 (0.67) HTR7DRD2DRD3DRD4MEN1
SCHEMBL10642850 0.70 DRD2 (0.70) HTR7DRD2DRD3DRD4MEN1
SCHEMBL6158309 0.70 HTR7 (0.88) HTR7
SCHEMBL6526368 0.70 DRD2 (0.85) HTR7DRD2DRD3MEN1HTR1A
SCHEMBL8854936 0.69 HTR1A (0.76) HTR7DRD2DRD3MEN1HTR1A
Hydrochloric Acid SCHEMBL8702916 0.69 HTR7 (0.57) HTR7DRD2DRD3MEN1HTR1A
SCHEMBL11825044 0.69 ADRA1A (0.81) HTR7DRD2DRD3MEN1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0624584-B1 Piperazine derivatives useful as calmodulin inhibitors DAIICHI SEIYAKU CO (JP) 1998-08-19 EP disclosed
EP-0624584-A1 Piperazine derivatives useful as calmodolin inhibitors DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1994-11-17 EP disclosed